Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Current Assets (2020 - 2025)

Celularity (CELU) has disclosed Current Assets for 6 consecutive years, with $12.3 million as the latest value for Q4 2025.

  • For Q4 2025, Current Assets fell 40.09% year-over-year to $12.3 million; the TTM value through Dec 2025 reached $12.3 million, down 40.09%, while the annual FY2025 figure was $12.3 million, 40.09% down from the prior year.
  • Current Assets hit $12.3 million in Q4 2025 for Celularity, up from $10.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $91.3 million in Q3 2021 and bottomed at $57811.0 in Q2 2021.
  • Average Current Assets over 5 years is $30.8 million, with a median of $20.2 million recorded in 2023.
  • Year-over-year, Current Assets crashed 92.91% in 2021 and then surged 130416.68% in 2022.
  • Celularity's Current Assets stood at $59.1 million in 2021, then tumbled by 43.31% to $33.5 million in 2022, then plummeted by 40.92% to $19.8 million in 2023, then increased by 3.88% to $20.6 million in 2024, then crashed by 40.09% to $12.3 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $12.3 million, $10.6 million, and $17.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.